What is NDC 0093-3127?

0093-3127 is the product NDC for Disopyramide Phosphate, Disopyramide phosphate 100 mg/1 capsule, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Disopyramide Phosphate?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Disopyramide Phosphate NDC 0093-3127

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-3127Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-3127Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-3127-01	0009331270100093312701	100 CAPSULE in 1 BOTTLE (0093-3127-01)Marketed from Sep 30, 1990

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Disopyramide Phosphate
Generic name (nonproprietary): disopyramide phosphate
Active ingredients: Disopyramide phosphate — 100 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070101
Marketing start: Sep 30, 1990
Listing expires: Dec 31, 2026
Identifiers: Product ID 0093-3127_82d9eecb-bbb9-4daf-863e-362ab0cbadafSPL ID 82d9eecb-bbb9-4daf-863e-362ab0cbadafSPL set ID 11a68e26-d2e4-48f6-ba0f-9bdd5778f25aRxCUI 309958, 309960UNII N6BOM1935WUPC 0300933129015, 0300933127011
Pharmacologic class: Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093312701 followed by a unit qualifier and the quantity

Package 00093-3127-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 25, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Disopyramide phosphate is indicated for the treatment of documented ventricular arrhythmias such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. Because of the proarrhythmic effects of disopyramide phosphate, its use with lesser arrhythmias is generally not recommended. Treatment of patients with asymptomatic ventricular premature contractions should be avoided. Initiation of disopyramide phosphate treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. Antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrh…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-3127

What is NDC 0093-3127?: 0093-3127 is the product NDC for Disopyramide Phosphate, Disopyramide phosphate 100 mg/1 capsule, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Disopyramide Phosphate.
What is the active ingredient?: Disopyramide phosphate.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Disopyramide Phosphate?: 5 other product NDCs are listed under this name. See all Disopyramide Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Disopyramide Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Disopyramide Phosphate	Disopyramide phosphate 150 mg/1	CapsuleOral	Dr. Reddy's Labratories Inc.	75907-026	75907-0026-01
Disopyramide Phosphate	Disopyramide phosphate 100 mg/1	CapsuleOral	Dr. Reddy's Labratories Inc.	75907-027	75907-0027-01
Disopyramide Phosphate	Disopyramide phosphate 100 mg/1	Capsule, Gelatin coatedOral	Mylan Pharmaceuticals Inc.	59762-0386	59762-0386-01
Disopyramide Phosphate	Disopyramide phosphate 150 mg/1	Capsule, Gelatin coatedOral	Mylan Pharmaceuticals Inc.	59762-0400	59762-0400-01
Disopyramide Phosphate	Disopyramide phosphate 150 mg/1	CapsuleOral	Teva Pharmaceuticals USA, Inc.	0093-3129	00093-3129-01